Influenza Vaccine in Pregnancy Part 2

Pregnant women have limited knowledge regarding influenza, its implications during pregnancy, and recommendations for vaccination during pregnancy. The researchers plan to distribute an information pamphlet to women in a prenatal clinic, offer the vaccine during prenatal visits, and then give a questionnaire on the postpartum floor assessing knowledge.

The researchers hypothesize that with education intervention, knowledge scores on the questionnaire will be higher than those from last year, when no education was provided.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Influenza Infections Influenza, Human Orthomyxoviridae Infections Pregnancy RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

14 year–46 year

Sex eligibility

Female

Study type

Observational

Primary location

St. Michael's Hospital

Toronto, Ontario, M5B1W8, Canada

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

all pregnant women

Exclusion criteria

known hypersensitivity to influenza vaccine

Treatment and study plan

Primary outcomes

Knowledge scores on our questionnaire

Time frame: 2 months

Sponsors and collaborators

Lead sponsor

Unity Health Toronto

Other

Registry information

Official study title

Knowledge Possessed by Pregnant Women Regarding Influenza Vaccination During Pregnancy

Important dates

Study start: 2007
Primary completion: 2013
Study completion: 2013
First posted: Jan 15, 2008
Registry last updated: Feb 22, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed